RT Journal Article
SR Electronic
T1 Sex differences in the influence of toxoplasmosis on stress and perceived anxiety: Evidence for the stress-coping hypothesis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.24.22269770
DO 10.1101/2022.01.24.22269770
A1 Jaroslav Flegr
A1 Šárka Kaňková
YR 2022
UL http://medrxiv.org/content/early/2022/01/25/2022.01.24.22269770.abstract
AB Life-long infection with Toxoplasma, which affects 30% of the human population, has specific behavioral effects. The stress-coping hypothesis explains why the toxoplasmosis-associated behavioral changes go in opposite directions in men and women. It suggests that toxoplasmosis impairs the health of humans, which results in chronic stress. Men and women are known to cope with stress in opposite ways. The first presumption of the hypothesis, impaired health, was confirmed in many studies. The second, higher level of stress, was tested only rarely. Levels of stress and anxiety, measured with the Perceived Stress Scale, and the State-Trait Anxiety Inventory X-2, respectively, were compared in a population of 614 Toxoplasma-free and 162 Toxoplasma-infected subjects. Higher stress was detected in the infected men, but not women. We also found that physical health had a positive rather than negative effect on stress when mental health is controlled, which seems to contradict the prediction of the stress-coping hypothesis. No differences were found in the anxiety of infected and noninfected subjects. Subjects who have objective reasons for stress (those with worse physical health) are less stressed than those without such reasons.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by Czech Science Foundation, grant number 18-13692S.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The project, including the method of obtaining informed consent to participate in this anonymous study from all participants by pressing the corresponding button on the first page of the questionnaire, was approved by the IRB of the Faculty of Science, Charles University (Komise pro praci s lidmi a lidskym materialem Prirodovedecke Fakulty Univerzity Karlovy) - No. 2019/30.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available at Fishare repository, doi.org/10.6084/m9.figshare.14651490.v1 (Flegr, 2021) https://doi.org/10.6084/m9.figshare.14651490.v1